Male, Female Veterans Have Increased Prevalence of Arthritis
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 14, 2023 -- Male and female veterans have a higher prevalence of arthritis than nonveterans, according to research published in the Nov. 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Elizabeth A. Fallon, Ph.D., from the CDC in Atlanta, and colleagues analyzed pooled data from the 2017 to 2021 Behavioral Risk Factor Surveillance System to estimate the prevalence of diagnosed arthritis among veterans and nonveterans.
The researchers found that about one-third of veterans had diagnosed arthritis (unadjusted prevalence, 34.7 and 31.9 percent among men and women, respectively). Among men aged 18 to 44 years, the prevalence of arthritis was double for veterans versus nonveterans (prevalence ratio, 2.1), while among men aged 45 to 64 years, the prevalence was 30 percent higher among veterans (prevalence ratio, 1.3). The corresponding prevalence ratios for veterans versus nonveterans among women aged 18 to 44 and 45 to 64 years were 1.6 and 1.2.
"Arthritis prevalence among veterans is higher than among nonveterans, especially among male and female veterans aged <45 years and those with disabilities, providing rationale for prioritizing these subgroups for secondary and tertiary prevention efforts," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-15 01:13
Read more
- Preventing, Treating Sports Injuries in Kids: A Guide
- Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk
- FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
- Using Abortion Pills Very Early in Pregnancy Is Safe, Study Finds
- U.S. Alcohol Intake Rose During Pandemic, and for Years After
- Kidney Transplants Safe When Donor, Recipient Both HIV-Positive
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions